Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Fontenay

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Blood Advances|March 17, 2023
FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cellsFrancoise Levavasseur, Samia Oussous, Tuerdi Zubaidan, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2015
Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parametersZahra Ajgal, Nicolas Chapuis, George Emile, et al.
Molecular Cancer Research : MCR|April 23, 2013
Epigenetic control of NF-κB-dependent FAS gene transcription during progression of myelodysplastic syndromesSandrine Ettou, Catherine Humbrecht, Blandine Benet, et al.
Oncoimmunology|December 21, 2020
No impact of cancer and plague-relevant <i>FPR1</i> polymorphisms on COVID-19Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli, et al.
British Journal of Haematology|June 20, 2019
Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective studyJohanna Mondesir, Anne-Sophie Alary, David Sibon, et al.
Plos One|May 3, 2013
Tyrosine kinase inhibitors induce down-regulation of c-Kit by targeting the ATP pocketDiane D'allard, Julie Gay, Clotilde Descarpentries, et al.
British Journal of Haematology|October 20, 2010
Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemiaBenoîte Pérez, Olivier Kosmider, Bruno Cassinat, et al.
European Journal of Pharmacology|November 29, 2020
Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life studySenade Atsou, Fiona Furlan, Jérôme Duchemin, et al.
Oncotarget|February 25, 2016
APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesisAnna Raimbault, Cecile Pierre-Eugene, Alexandra Rouquette, et al.
Cytometry. Part B, Clinical Cytometry|April 10, 2019
The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromesAnna Raimbault, Raphael Itzykson, Lise Willems, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Blood Advances|March 17, 2023
FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cellsFrancoise Levavasseur, Samia Oussous, Tuerdi Zubaidan, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2015
Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parametersZahra Ajgal, Nicolas Chapuis, George Emile, et al.
Molecular Cancer Research : MCR|April 23, 2013
Epigenetic control of NF-κB-dependent FAS gene transcription during progression of myelodysplastic syndromesSandrine Ettou, Catherine Humbrecht, Blandine Benet, et al.
Oncoimmunology|December 21, 2020
No impact of cancer and plague-relevant <i>FPR1</i> polymorphisms on COVID-19Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli, et al.
British Journal of Haematology|June 20, 2019
Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective studyJohanna Mondesir, Anne-Sophie Alary, David Sibon, et al.
Plos One|May 3, 2013
Tyrosine kinase inhibitors induce down-regulation of c-Kit by targeting the ATP pocketDiane D'allard, Julie Gay, Clotilde Descarpentries, et al.
British Journal of Haematology|October 20, 2010
Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemiaBenoîte Pérez, Olivier Kosmider, Bruno Cassinat, et al.
European Journal of Pharmacology|November 29, 2020
Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life studySenade Atsou, Fiona Furlan, Jérôme Duchemin, et al.
Oncotarget|February 25, 2016
APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesisAnna Raimbault, Cecile Pierre-Eugene, Alexandra Rouquette, et al.
Cytometry. Part B, Clinical Cytometry|April 10, 2019
The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromesAnna Raimbault, Raphael Itzykson, Lise Willems, et al.
Pageof 11